Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['ovarian', 'imfinzi', 'lynparza', 'astrazeneca']
asco: astrazeneca guns for wider ovarian cancer market with imfinzi-lynparza combo. will the fda buy the plan? 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.